Select another language
Select another language

Justin Stindt Consultants – Global Market Access Agency with Expertise Across US, European and International Markets

In an increasingly interconnected global marketplace, understanding and adapting to the nuances of different markets is crucial for Market Access success. Our company supports pharma, biotech and medtech clients with Global Market Access and country-specific solutions in major markets such as the United States, France, Germany, Italy, Spain, Switzerland and the United Kingdom. Our agency Justin Stindt Consultants consists of experts with both Global Market Access expertise and local experience in all major markets. Our consultancy also has a broad network of local experts and partners in all major international markets to provide global solutions to our clients. 

In each of these markets, our consulting firm leverages our expertise to tailor market access strategies that address specific challenges in each market while guaranteeing consistency with global strategy.

For more information on market access in a specific market (EU or US), click the links below:

Justin Stindt Consultants is your agency to support you with global Market Access

Justin Stindt Consultants is your consulting firm with experts who have extensive experience in Market Access in international markets. Our skilled consultants can help you with market access activities such as pricing and reimbursement strategies, funding pathways, early advice meetings, pricing negotiations, ad boards, early access programme feasibility assessments and dossier submissions, pricing and reimbursement dossier preparations and submissions etc.

For more information about the services our agency provides, go to Pricing & Reimbursement Strategy, Pricing & Reimbursement Dossiers, Payer & HTA Engagement.

Connect with our team

Our experienced Market Access specialists are just a click away



The Pharma industry is characterized by long research & development cycles and complex Market Access, but once successful, medicines can achieve universal reimbursement.


The biotech industry faces largely the same challenges & opportunities as the pharma industry but in addition to this financing rounds and Business Development & Licensing discussions play a pivotal role on the road towards successful Market Access.

Medical Devices

While regulatory approval is typically faster for Medical Devices compared to medicines, Pricing & Reimbursement is typically more complex and fragmented. Market Access for Medical Devices is a dynamic process which needs to be strategically managed throughout the product lifecycle.

e-Health / Digital Health

Market Access pathways for E-Health / Digital Health solutions are emerging and span from pilot projects to regular reimbursement pathways in key markets.

Our News